R.PR
REGISTERED-PRINCIPAL REGISTER
02/15/2022
Back to search
Official data from USPTO
INTERLINE THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INTERLINE THERAPEUTICS
ST13
US500000090218075Class
42
Filing
90218075
Registration
6647730
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
02/15/2022
Trademark type
Word
Nice classes
42
Filing date
09/28/2020
Registration date
02/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/15/2022
Last transaction
02/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/13/2021
First use in commerce
05/13/2021
Drawing code
4
Owner type
03
Owner location
SOUTH SAN FRANCISCO, CA, US
Examiner
QUEEN, ESTHER FELICIA
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
INTERLINE THERAPEUTICS, INC.
Foresite Labs, LLC
Foresite Labs, LLC
Representatives
Andrew T. Rissler PATEL & ALMEIDA, P. C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceuticals research and development; Scientific and medical research and information services in the field of pharmaceutical development; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Research and development of therapeutic drugs for the prevention or treatment of human diseases; Scientific research in the field of drug discovery and development for others; Biomedical research services; Scientific research; Preclinical development of therapeutic product
Publications
History of USPTO decisions and trademark events.
26 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/08/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/07/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/14/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/13/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/08/2021
IUAF
USE AMENDMENT FILED
11/12/2021
EISU
TEAS STATEMENT OF USE RECEIVED
11/12/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/28/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/28/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/28/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/28/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/28/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/20/2021
PUBO
PUBLISHED FOR OPPOSITION
04/20/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/31/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/24/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/24/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/24/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/24/2021
DOCK
ASSIGNED TO EXAMINER
02/18/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
01/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2020
NWAP
NEW APPLICATION ENTERED
10/01/2020
Continuous trademark protection
Get notified about every new filing that threatens INTERLINE THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.